GYNAECOLOGY CANCER RESEARCH FUND

Registered charity 1091708 · accounts filings on the Charity Commission register · also known as EVE APPEAL, GCRF, GYNAECOLOGICAL CANCER RESEARCH UK, GYNAECOLOGICAL CANCER UK, GYNAECOLOGY CANCER RESEARCH UK, GYNAECOLOGY CANCER UK · also registered in Scotland as SC042612 (OSCR)

The Eve Appeal's vision is a future where fewer women develop and more women survive the five gynaecological cancers. To achieve this vision we raise money to support and fund world-class research into the five gynaecological cancers alongside raising awareness of them. The five gynaecological cancers are ovarian, cervical, vulval, vaginal and womb (also known as endometrial or uterine).

Objects

TO ADVANCE AND FUND RESEARCH INTO GYNAECOLOGICAL CANCERS AND DISSEMINATE THE RESULTS OF SUCH RESEARCH. TO ADVANCE PUBLIC EDUCATION AND THEREBY TO RAISE AWARENESS OF AND THE PROFILE OF GYNAECOLOGICAL CANCERS, THEIR SIGNS AND SYMPTOMS, RISK FACTORS (INCLUDING BRCA AND INHERITED RISKS). TO RELIEVE THE NEEDS OF WOMEN AFFECTED BY GYNAECOLOGICAL CANCERS, AND INHERITED RISK FACTORS (INCLUDING GENETIC MUTATIONS) BY PROVIDING INFORMATION AND SUPPORT SERVICES FOR SUCH WOMEN, THEIR FAMILIES, FRIENDS AND HEALTH AND SOCIAL CARE PROFESSIONALS.?

Area of benefit: NOT DEFINED

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Registered contact address: Southwark, London, England (from the postcode on the register)

Latest income
£1.7m
Latest spending
£1.9m
Registered
2002
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity ended the year with £389,168 in unrestricted reserves, which is £189,168 above its agreed operating reserve target of £200,000. The charity reported a net surplus for the year and holds an overall cash balance of £1,081,311. The trustees consider the charity to be well-placed to manage risks and have no material uncertainties regarding its ability to continue as a going concern.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: three months’ budgeted expenditure, excluding expenditure on research grants and restricted charitable activities (reserves figure: £389k)
“In real terms, £200,000 represents just under three months’ budgeted expenditure, excluding expenditure on research grants and restricted charitable activities.”
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Donations from Trustees
“During the year under review, the charity received income totalling £14,550 in donations from 9 Trustees, both current and resigned in the period, including partners (2024: £18,070 from 9 Trustees including partners).” — page 56
“Reed Smith LLP provided pro bono legal services and other support to the charity totalling £50,113 (2024: 80,116). Tamara Box, a partner at Reed Smith LLP is also chair of board of trustee of the charity.” — page 56
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Pro bono legal services from Reed Smith LLP (connected to Trustee Tamara Box)
“During the year under review, the charity received income totalling £14,550 in donations from 9 Trustees, both current and resigned in the period, including partners (2024: £18,070 from 9 Trustees including partners).” — page 56
“Reed Smith LLP provided pro bono legal services and other support to the charity totalling £50,113 (2024: 80,116). Tamara Box, a partner at Reed Smith LLP is also chair of board of trustee of the charity.” — page 56
Per its FY2025 accounts as filed with the Charity Commission.
Trading subsidiary: Eve Appeal Limited
“The Charity had one 100% owned subsidiary company in the year. Eve Appeal Limited is a trading company that distributes its profits under Gift Aid to the Charity.” — page 28
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Moore Kingston Smith LLP. Discloses 4 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/12/2025

  • Volunteers: 66
  • Government income: £31,351 — grants £31,351 (1); 2% of the £1,729,124 total gross income on the same return
  • Employees paid over £60,000: 2 (£70,001–£80,000: 1; £90,001–£100,000: 1)
  • Has a trading subsidiary
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/12/2024

  • Volunteers: 60
  • Government income: £143,121 — grants £143,121 (1); 8% of the £1,782,838 total gross income on the same return
  • Employees paid over £60,000: 2 (£70,001–£80,000: 1; £90,001–£100,000: 1)
  • Has a trading subsidiary
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/12/2023

  • Government income: £182,275 — grants £182,275 (1); 14% of the £1,344,858 total gross income on the same return
  • Employees paid over £60,000: 2 (£60,001–£70,000: 1; £90,001–£100,000: 1)
  • Has a trading subsidiary
  • Grant-making is its main activity

Source: this charity’s annual returns on the Charity Commission register.

Corporate structure

EVE APPEAL LIMITED — per its own Companies House accounts
  • Turnover: £152k
  • Profit before tax: £152k
  • Donated/gift-aided to the charity: £104k
  • },
“Distributions to parent charity under gift aid”

Company officers (Companies House)

Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.

Official officers record.

Structured financials (annual return, FY ending 31/12/2025)

Total income
£1.7m
Total spending
£1.9m
Cost of raising funds
£633k
Reserves (reported)
£200k
Employees
17

Reported reserves equal ~1.2 months of spending — in the bottom quarter for charities its size (median 4.7 months; benchmarks).

Per its annual return, largest income source: Donations and legacies (90% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 36.6% of total income — above the 90th percentile for charities its size (median 5.3%) (benchmarks).

Register events

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales · United States

Income and spending

Financial year endIncomeSpending
31/12/2025£1.7m£1.9m
31/12/2024£1.8m£1.7m
31/12/2023£1.3m£1.6m
31/12/2022£1.6m£1.7m
31/12/2021£1.5m£1.1m

Common questions

Is GYNAECOLOGY CANCER RESEARCH FUND financially healthy?

Per its FY2025 accounts: The accounts state that the charity ended the year with £389,168 in unrestricted reserves, which is £189,168 above its agreed operating reserve target of £200,000. The charity reported a net surplus for the year and holds an overall cash balance of £1,081,311. The trustees consider the charity to be well-placed to manage risks and have no material uncertainties regarding its ability to continue as a going concern. Its FY2025 accounts were audited by Moore Kingston Smith LLP.

Who funds GYNAECOLOGY CANCER RESEARCH FUND?

Funders whose own accounts filings name GYNAECOLOGY CANCER RESEARCH FUND as a grant recipient include THE ORR MACKINTOSH FOUNDATION LIMITED, THE PETER STEBBINGS MEMORIAL CHARITY, THE INMAN CHARITY, SANDRA CHARITABLE TRUST, THE GROCERS' CHARITY.

Known funders

Grants to this charity found in funders’ own accounts filings.

FunderYearAmountPurpose (as stated by the funder)
THE ORR MACKINTOSH FOUNDATION LIMITEDFY2025£10k
THE PETER STEBBINGS MEMORIAL CHARITYFY2021£10k
THE INMAN CHARITYFY2023£7kMedical - Research
SANDRA CHARITABLE TRUSTFY2025£5k
THE GROCERS' CHARITYFY2021£5kHealth
SCHRODER CHARITY TRUSTFY2024£5k
THE PETER STEBBINGS MEMORIAL CHARITYFY2024£5k
SANDRA CHARITABLE TRUSTFY2024£5kGrant paid or payable
THE GROCERS' CHARITYFY2024£5kHealth
SANDRA CHARITABLE TRUSTFY2021£4k
THE HILARY AWDRY CHARITABLE TRUSTFY2022£3k
THE LAWSON TRUST CIOFY2021£2k
THE BLYTH WATSON CHARITABLE TRUSTFY2024£2k
THE BLYTH WATSON CHARITABLE TRUSTFY2023£2k
MRS WINGFIELD'S CHARITABLE TRUSTFY2021£2k
THE OAKDALE TRUSTFY2023£2k
THE HILARY AWDRY CHARITABLE TRUSTFY2024£1k
THE HILARY AWDRY CHARITABLE TRUSTFY2023£1k
THE HILARY AWDRY CHARITABLE TRUSTFY2021£1k
THE OAKDALE TRUSTFY2021£1k
LSEG FoundationFY2022£370
THE PETER STEBBINGS MEMORIAL CHARITYFY2025amount not stated
THE HISCOX FOUNDATIONFY2025amount not stated
THE HOSPITAL SATURDAY FUNDFY2021amount not statedresearch programme into ovarian cancer and the microbiome

Government & lottery funding

Grants to this charity published as open data by government and lottery funders (360Giving).

FunderDateAmountPurpose
UK government11/09/2020£9kCoronavirus Community Support Fund

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with OVARIAN CANCER ACTION.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
GYNAECOLOGY CANCER RESEARCH FUND£1.7m——above—no doubt
OVARIAN CANCER ACTION FY2025£1.6m£150,001 - £160,0003unclear50.2%no doubt
GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE") FY2025£92k—0below—no doubt
OVACOME FY2025£878k——unclear—no doubt
TARGET OVARIAN CANCER FY2025£3.4m£130,001 - £140,000—above—no doubt
THE BRITISH GYNAECOLOGICAL CANCER SOCIETY FY2025£554k——above—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.